Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.49 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.49 |
| ▸ | RELA | Q04206 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | LPL | P06858 | 1/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.43 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL415439 | 0.93 | POLB (0.62) | POLBCTDSP1TAAR1HTR2AMAPK1 | |
| SCHEMBL6773382 | 0.90 | POLB (0.60) | POLBCTDSP1TAAR1HTR2AMAPK1 | |
| Ammonia Solution, Strong SCHEMBL27502612 | 0.90 | POLB (0.60) | POLBCTDSP1TAAR1HTR2AMAPK1 | |
| SCHEMBL18758172 | 0.88 | POLB (0.51) | POLBCTDSP1TAAR1HTR2AMAPK1 | |
| SCHEMBL8951012 | 0.88 | POLB (0.58) | POLBCTDSP1TAAR1HTR2AMAPK1 | |
| SCHEMBL4802707 | 0.87 | LPL (0.54) | NPC1RAB9ALPLLIPGMCL1 | |
| SCHEMBL2050263 | 0.86 | NPC1 (0.64) | TAAR1HTR2AMAPK1NPC1RAB9A | |
| SCHEMBL1599747 | 0.85 | RARB (0.58) | HTR2AMAPK1NPC1RAB9ANFKB1 | |
| SCHEMBL22989786 | 0.83 | HSD17B10 (0.61) | HTR2AMAPK1NPC1RAB9ANFKB1 | |
| SCHEMBL10455067 | 0.83 | HSD17B10 (0.61) | HTR2AMAPK1NPC1RAB9ANFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514631-A | Synthesis method of high-purity 4-bromo-4' -propyl biphenyl | 中国船舶集团有限公司第七一八研究所 | 2023-08-01 | — | — | CN | claimed |
| CN-108129258-B | Synthesis process of 4-bromo-4' -propylbiphenyl | 上海仁实医药科技有限公司 | 2021-01-29 | — | — | CN | claimed |
| US-12628546-B2 | Polymer and organic light-emitting diode using same | LG CHEM, LTD. (KR) | 2026-05-12 | — | — | US | disclosed |
| US-20250294961-A1 | Polymer and Organic Light-Emitting Device Using Same | LG CHEM, LTD. (KR) | 2025-09-18 | — | — | US | disclosed |
| EP-4368652-B1 | POLYMER AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG CHEMICAL LTD (KR) | 2025-04-30 | — | — | EP | disclosed |
| CN-118179592-B | Preparation method and application of bromodiphenyl oxide composite catalyst | 安徽泰达新材料股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| EP-4071193-B1 | NOVEL POLYMER AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEMICAL LTD (KR) | 2025-03-12 | — | — | EP | disclosed |
| US-20240368463-A1 | Polymer and Organic Light-Emitting Device Using Same | LG CHEM, LTD. (KR) | 2024-11-07 | — | — | US | disclosed |
| EP-4400526-A1 | POLYMER AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2024-07-17 | — | — | EP | disclosed |
| EP-4400526-A1 | POLYMER AND ORGANIC LIGHT-EMITTING DEVICE USING SAME | LG Chem, Ltd. (KR) | 2024-07-17 | — | — | EP | disclosed |
| CN-118271184-A | Dendritic structural compound, compound thereof and organic electroluminescent device | 中国科学院长春应用化学研究所 | 2024-07-02 | — | — | CN | disclosed |
| US-5712396-A | PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS | MAGNIN DAVID R (US) | 1998-01-27 | — | — | US | disclosed |
| US-5637257-A | LIQUID CRYSTAL DISPLAYING | MERCK PATENT GESELLSCHAFT MLT BESCHRANKTER HAFTUNG (DE) | 1997-06-10 | — | — | US | disclosed |
| US-5567841-A | ANTICHOLESTEROL AGENT | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-22 | — | — | US | disclosed |
| US-5482653-A | FOR LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1996-01-09 | — | — | US | disclosed |
| EP-0413785-B1 | LIQUID CRYSTALLINE MEDIA CONTAINING FLUORINATED OLIGOPHENYLS | MERCK PATENT GMBH (DE) | 1995-12-20 | — | — | EP | disclosed |
| US-5470845-A | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-11-28 | — | — | US | disclosed |
| EP-0428666-B1 | FLUORO-CHLORO-BENZENE DERIVATIVES | MERCK PATENT GMBH (DE) | 1995-03-15 | — | — | EP | disclosed |
| EP-0595635-A1 | Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors | E.R. Squibb & Sons, Inc. (US) | 1994-05-04 | — | — | EP | disclosed |
| WO-1990015113-A1 | FLUORO-CHLORO-BENZENE DERIVATIVES | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1990-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12628546-B2 | Polymer and organic light-emitting diode using same | CCNE2, CCNL2, CCNB1 | POLB 1980/4885CTDSP1 3037/4885TAAR1 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.